UNSPSC 51332823: Phenothiazine

This classification denotes an antiemetic agent with the molecular formula C12H9NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GS9EX7QNU6, chemically known as 10h-phenothiazine-10-propanamine, 2-chloro-n,n-dimethyl-, radical ion(1+) but generally known as phenothiazine, which bears US NIH Compound Identifier 2726. European Medicines Agency schedules Phenothiazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09776MIG. The term PHENOTHIAZINE is an International Non-Proprietary Name.

UNSPSC 51332823 Phenothiazine is a Commodity code that does not align with the state and local procurement activity currently posted under it. The recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which are phenothiazine drugs or phenothiazine-specific solicitations. The mismatch suggests either a tagging error in the source data or a misalignment between the code's nominal scope and how state and local procurement systems classify pharmaceutical purchases in practice.

The issuing bodies posting under this code include a county health department (Seminole County, Florida), a state HHS commission (Texas Health and Human Services Commission), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating jurisdictions). Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems with a July 26, 2023 response deadline, Texas HHS's RFI on direct-to-manufacturer prescription programs posted April 3, 2026, and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline. The geographic spread covers Florida, Texas, and Minnesota-Oregon partnership jurisdictions. Because the code shows no relevant recent activity aligned to phenothiazine products specifically, this code warrants scrutiny before pursuing opportunities flagged under it — verify the actual product or service scope in each solicitation before investing in response preparation.